ReP USP - Resultado da busca

Filtros : "AM251" Limpar

Filtros

Artigo de periodico
Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action (2021)
Chaves, Yane Costa; Genaro, Karina; Crippa, José Alexandre de Souza ; Cunha, Joice Maria da; Zanoveli, Janaina Menezes
Source: Metabolic Brain Disease. Unidade: FMRP
Subjects: ANSIOLÍTICOS, ANTIDEPRESSIVOS, CANABINOIDES, DIABETES MELLITUS, FARMACOTERAPIA, SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Yane Costa et al. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease, v. 36, n. 4, p. 639-652, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11011-020-00667-3. Acesso em: 26 jan. 2026.
APA
Chaves, Y. C., Genaro, K., Crippa, J. A. de S., Cunha, J. M. da, & Zanoveli, J. M. (2021). Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease, 36( 4), 639-652. doi:10.1007/s11011-020-00667-3
NLM
Chaves YC, Genaro K, Crippa JA de S, Cunha JM da, Zanoveli JM. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action [Internet]. Metabolic Brain Disease. 2021 ; 36( 4): 639-652.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1007/s11011-020-00667-3
Vancouver
Chaves YC, Genaro K, Crippa JA de S, Cunha JM da, Zanoveli JM. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action [Internet]. Metabolic Brain Disease. 2021 ; 36( 4): 639-652.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1007/s11011-020-00667-3
Artigo de periodico
CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy (2016)
Medeiros, P.; Freitas, R. L. de; Silva, M. O.; Coimbra, Norberto Cysne; Melo-Thomaz, L
Source: Neuroscience. Unidade: FMRP
Subjects: CANABINOIDES, RECEPTORES, CATALEPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS, P. et al. CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy. Neuroscience, v. 337, p. 17-26, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.neuroscience.2016.08.047. Acesso em: 26 jan. 2026.
APA
Medeiros, P., Freitas, R. L. de, Silva, M. O., Coimbra, N. C., & Melo-Thomaz, L. (2016). CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy. Neuroscience, 337, 17-26. doi:10.1016/j.neuroscience.2016.08.047
NLM
Medeiros P, Freitas RL de, Silva MO, Coimbra NC, Melo-Thomaz L. CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy [Internet]. Neuroscience. 2016 ; 337 17-26.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1016/j.neuroscience.2016.08.047
Vancouver
Medeiros P, Freitas RL de, Silva MO, Coimbra NC, Melo-Thomaz L. CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy [Internet]. Neuroscience. 2016 ; 337 17-26.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1016/j.neuroscience.2016.08.047

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2026